Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
Key Information
Due Date: February 3, 2026
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI), also known as R35 (Clinical Trial Optional), is a Notice of Funding Opportunity (NOFO) that supports research programs connected to the National Institute of General Medical Sciences (NIGMS) mission. Specifically, it aims to provide funding for a series of related projects within an early stage investigator's lab that align with the NIGMS's objectives. The overarching goal of the MIRA initiative is to enhance the effectiveness and efficiency of NIGMS funding.
Show More
Key Dates
Open Date: April 24, 2023
Application Due Date: February 3, 2026
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses